Dysport® is the first botulinum toxin to achieve positive topline Phase III results in both episodic and chronic migraine.
🤖 D.R.A.F.T. Summary
Dysport® is the first botulinum toxin to achieve positive topline Phase III results in both episodic and chronic migrain
Dysport® achieved statistically significant topline Phase III results, meeting primary endpoints in both episodic (E-BEOND) and chronic (C-BEOND) migraine Dysport is the first botulinum toxin in episodic migraine to demonstrate a statistically significant reduction in monthly migraine days Dysport was well-tolerated across both trials with safety consistent with the known profile PARIS, FRANCE – 9 […]
Outlets covering this story
Financial Post
CENTER
Only one perspective covered this story — no diversity detected
Side-by-Side Outlet Comparison — Starter+
See how 1 outlets framed this story — bias by source, F.A.C.T. framing analysis, and verdict side by side.
Unlock with Starter →